| Ident. | Authors (with country if any) | Title |
|---|
| 000318 (2020) |
Peter Uciechowski [Allemagne] ; Wolfram C M. Dempke [Allemagne] | Interleukin-6: A Masterplayer in the Cytokine Network. |
| 000614 (2020) |
Haneul Kim [Corée du Sud] ; Seungye Baek [Corée du Sud] ; Seung-Min Hong [Corée du Sud] ; Jaeseon Lee [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jennifer Lee [Corée du Sud] ; Mi-La Cho [Corée du Sud] ; Seung-Ki Kwok [Corée du Sud] ; Sung-Hwan Park [Corée du Sud] | 1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis |
| 000681 (2019) |
Santos Casta Eda [Espagne] ; Noelia García-Casta Eda [Espagne] ; Diana Prieto-Pe A [Espagne] ; Dolores Martínez-Quintanilla [Espagne] ; Esther F. Vicente [Espagne] ; Ricardo Blanco [Espagne] ; Miguel A. González-Gay [Afrique du Sud] | Treatment of polymyalgia rheumatica. |
| 000706 (2019) |
Martina Biggioggero [Oman] ; Chiara Crotti [Italie] ; Andrea Becciolini [Oman] ; Ennio Giulio Favalli [Oman] | Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection. |
| 000715 (2019) |
Santos Casta Eda [Espagne] ; Dolores Martínez-Quintanilla [Espagne] ; José L. Martín-Varillas [Espagne] ; Noelia García-Casta Eda [Espagne] ; Belén Atienza-Mateo [Espagne] ; Miguel A. González-Gay [Espagne] | Tocilizumab for the treatment of adult-onset Still's disease. |
| 000719 (2019) |
Kazutoshi Ebisawa [Japon] ; Yosuke Masamoto [Japon] ; Junji Tokushige [Japon] ; Hiroshi Nishi [Japon] ; Kenjiro Honda [Japon] ; Munetoshi Hinata [Japon] ; Kazuhiro Toyama [Japon] ; Masaomi Nangaku [Japon] ; Mineo Kurokawa [Japon] | Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease. |
| 000724 (2019) |
Levente Bodoki [Hongrie] ; Edit Végh [Hongrie] ; Zoltán Szekanecz [Hongrie] ; Gabriella Sz Cs [Hongrie] | Tocilizumab Treatment in Polyarteritis Nodosa. |
| 000739 (2019) |
Niklas Prenissl [Allemagne] ; Juliane Lokau [Allemagne] ; Stefan Rose-John [Allemagne] ; Johannes Haybaeck [Autriche] ; Christoph Garbers [Allemagne] | Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage. |
| 000788 (2019) |
Hind Hashwah ; Katrin Bertram ; Kristin Stirm ; Anna Stelling ; Cheuk-Ting Wu ; Sabrina Kasser ; Markus G. Manz ; Alexandre P. Theocharides ; Alexandar Tzankov ; Anne Müller | The IL‐6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B‐cell lymphoma |
| 000830 (2019) |
Atsushi Ogata [Japon] ; Yasuhiro Kato [Japon] ; Shinji Higa [Japon] ; Keiji Maeda [Japon] | Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritis. |
| 000850 (2019) |
Thor Ueland [Norvège] ; Ola Kleveland [Norvège] ; Annika E. Michelsen [Norvège] ; Rune Wiseth [Norvège] ; Jan Kristian Dam S [Norvège] ; Kirsten B. Holven [Norvège] ; P L Aukrust [Norvège] ; Lars Gullestad [Norvège] ; Arne Yndestad [Norvège] ; Bente Halvorsen [Norvège] | Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction. |
| 000984 (2019) |
Florian Kleinegger [Autriche] ; Eva Hofer [Autriche] ; Christina Wodlej [Autriche] ; Nicole Golob-Schwarzl [Autriche] ; Anna Maria Birkl-Toeglhofer [Autriche] ; Alexander Stallinger [Autriche] ; Johannes Petzold [Autriche] ; Anna Orlova [Autriche] ; Stefanie Krassnig [Autriche] ; Robert Reihs [Autriche] ; Tobias Niedrist [Autriche] ; Harald Mangge [Autriche] ; Young Nyun Park [Corée du Sud] ; Michael Thalhammer [Autriche] ; Ariane Aigelsreiter [Autriche] ; Sigurd Lax [Autriche] ; Christoph Garbers [Allemagne] ; Peter Fickert [Autriche] ; Stefan Rose-John [Allemagne] ; Richard Moriggl [Autriche] ; Beate Rinner [Autriche] ; Johannes Haybaeck [Allemagne] | Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival. |
| 000B00 (2019) |
Yueh-Shan Weng [Taïwan] ; Hong-Yu Tseng [Taïwan] ; Yen-An Chen [Taïwan] ; Pei-Chun Shen [Taïwan] ; Aushia Tanzih Al Haq [Taïwan] ; Li-Mei Chen [Taïwan] ; Yi-Chung Tung [Taïwan] ; Hsin-Ling Hsu [Taïwan] | MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. |
| 000B21 (2019) |
Cynthia M. Magro [États-Unis] ; Pierre Halteh [États-Unis] ; Luke C. Olson [États-Unis] ; Ilya Kister [États-Unis] ; Lee Shapiro [États-Unis] | Linear scleroderma “en coup de sabre” with extensive brain involvement—Clinicopathologic correlations and response to anti-Interleukin-6 therapy |
| 000C20 (2019) |
N. Kamiya [Japon] ; G. Kuroyanagi [États-Unis] ; O. Aruwajoye [États-Unis] ; H K W. Kim [États-Unis] | IL6 receptor blockade preserves articular cartilage and increases bone volume following ischemic osteonecrosis in immature mice. |
| 000C21 (2019) |
Hassan Yousefi [Iran] ; Majid Momeny [Iran] ; Seyed H. Ghaffari [Iran] ; Nazanin Parsanejad [Iran] ; Arash Poursheikhani [Iran] ; Sepehr Javadikooshesh [Iran] ; Ghazaleh Zarrinrad [Iran] ; Fatemeh Esmaeili [Iran] ; Zivar Alishahi [Iran] ; Zahra Sabourinejad [Iran] ; Ghazaleh Sankanian [Iran] ; Sahar Shamsaiegahkani [Iran] ; Davood Bashash [Iran] ; Narjes Shahsavani [Canada] ; Javad Tavakkoly-Bazzaz [Iran] ; Kamran Alimoghaddam [Iran] ; Ardeshir Ghavamzadeh [Iran] | IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer. |
| 000C58 (2019) |
Fiona Coath [Royaume-Uni] ; Kate Gillbert [Royaume-Uni] ; Bridget Griffiths [Royaume-Uni] ; Frances Hall [Royaume-Uni] ; Lesley Kay [Royaume-Uni] ; Peter Lanyon [Royaume-Uni] ; Raashid Luqmani [Royaume-Uni] ; Sarah L. Mackie [Royaume-Uni] ; Justin C. Mason [Royaume-Uni] ; John Mills [Royaume-Uni] ; Susan Mollan [Royaume-Uni] ; Ann W. Morgan [Royaume-Uni] ; Chetan Mukhtyar [Royaume-Uni] ; Vanessa Quick [Royaume-Uni] ; Richard Watts [Royaume-Uni] ; Bhaskar Dasgupta [Royaume-Uni] | Giant cell arteritis: new concepts, treatments and the unmet need that remains. |
| 000C91 (2019) |
Scott Fettner [États-Unis] ; Christopher Mela [Royaume-Uni] ; Florian Wildenhahn [Suisse] ; Monica Tavanti [Suisse] ; Christine Wells [Royaume-Uni] ; Wendy Douglass [Royaume-Uni] ; Navita L. Mallalieu [États-Unis] | Evidence of bioequivalence and positive patient user handling of a tocilizumab autoinjector. |
| 000D27 (2019) |
Elinoar Hoffman ; Michal A. Rahat ; Joy Feld ; Muna Elias ; Itzhak Rosner ; Lisa Kaly ; Idit Lavie [Israël] ; Tal Gazitt ; Devy Zisman | Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis |
| 000D46 (2019) |
Iván Ferraz-Amaro [Espagne] ; María Vanesa Hernández-Hernández [Espagne] ; Beatriz Tejera-Segura [Espagne] ; Esmeralda Delgado-Frías [Espagne] ; María Macía-Díaz [Espagne] ; Jose David Machado [Espagne] ; Federico Diaz-González [Espagne] | Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients. |
| 000F69 (2019) |
Nuria Vegas-Revenga [Espagne] ; Vanesa Calvo-Río [Espagne] ; Marina Mesquida [Espagne] ; Alfredo Adán [Espagne] ; María Victoria Hernández [Espagne] ; Emma Beltrán [Espagne] ; Elia Valls Pascual [Espagne] ; David Díaz-Valle [Espagne] ; Gisela Díaz-Cordovés [Espagne] ; Marisa Hernandez-Garfella [Espagne] ; Lucía Martínez-Costa [Espagne] ; Inmaculada Calvo [Espagne] ; Antonio Atanes [Espagne] ; Luis F. Linares [Espagne] ; Consuelo Modesto [Espagne] ; Carmen González-Vela [Espagne] ; Rosalia Demetrio-Pablo [Espagne] ; Elena Aurrecoechea [Espagne] ; Miguel Cordero [Espagne] ; Lucía C. Domínguez-Casas [Espagne] ; Belén Atienza-Mateo [Espagne] ; José Luis Martín-Varillas [Espagne] ; Javier Loricera [Espagne] ; Natalia Palmou-Fontana [Espagne] ; José L. Hernández [Espagne] ; Miguel A. González-Gay [Espagne] ; Ricardo Blanco [Espagne] | Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients. |
| 001011 (2019) |
Cécile Luxembourger [France] ; Adeline Ruyssen-Witrand [France] ; Chayma Ladhari [France] ; Cécile Rittore [France] ; Yannick Degboe [France] ; Jean-Francis Maillefert [France] ; Philippe Gaudin [France] ; Hubert Marotte [France] ; Daniel Wendling [France] ; Christian Jorgensen [France] ; Alain Cantagrel [France] ; Arnaud Constantin [France] ; Delphine Nigon [France] ; Isabelle Touitou [France] ; Jacques-Eric Gottenberg [France] ; Yves-Marie Pers [France] | A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients. |
| 001024 (2019) |
Tomohiro Koga [Japon] ; Remi Sumiyoshi [Japon] ; Atsushi Kawakami [Japon] ; Kazuyuki Yoshizaki [Japon] | A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease. |
| 001108 (2018) |
Xiufang Kong [République populaire de Chine] ; Xiaojie Zhang [République populaire de Chine] ; Peng Lv [République populaire de Chine] ; Xiaomeng Cui [République populaire de Chine] ; Lili Ma [République populaire de Chine] ; Huiyong Chen [République populaire de Chine] ; Hao Liu [République populaire de Chine] ; Jiang Lin [République populaire de Chine] ; Lindi Jiang [République populaire de Chine] | Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide. |
| 001118 (2018) |
Tao-Cheng Wu [Taïwan] ; Chih-Yao Chiang [Taïwan] ; Jenq-Shyong Chan [Taïwan] ; Chiu-Yang Lee [Taïwan] ; Hsin-Bang Leu [Taïwan] ; Po-Hsun Huang [Taïwan] ; Jia-Shiong Chen [Taïwan] ; Shing-Jong Lin [Taïwan] ; Jaw-Wen Chen [Taïwan] | Tocilizumab, a Humanized Monoclonal Antibody Against the Interleukin-6 Receptor, Inhibits High Glucose-Induced Vascular Smooth Muscle Cell Migration Through Mitogen-Activated Protein Kinase Signaling Pathways. |
| 001126 (2018) |
Matthew B. Carroll [États-Unis] | Tocilizumab in the treatment of myocardial infarction. |
| 001127 (2018) |
Nicolai Leuchten [Allemagne] ; Martin Aringer [Allemagne] | Tocilizumab in the treatment of giant cell arteritis. |
| 001128 (2018) |
Raimon Sanmartí [Espagne] ; Virginia Ruiz-Esquide [Espagne] ; Carla Bastida [Espagne] ; Dolor Soy [Espagne] | Tocilizumab in the treatment of adult rheumatoid arthritis. |
| 001135 (2018) |
Michael Schirmer [Autriche] ; Francesco Muratore [Italie] ; Carlo Salvarani [Italie] | Tocilizumab for the treatment of giant cell arteritis. |
| 001149 (2018) |
Christopher P. Denton [Royaume-Uni] ; Voon H. Ong [Royaume-Uni] ; Shiwen Xu [Royaume-Uni] ; Haiyin Chen-Harris [États-Unis] ; Zora Modrusan [États-Unis] ; Robert Lafyatis [États-Unis] ; Dinesh Khanna [États-Unis] ; Angelika Jahreis [États-Unis] ; Jeffrey Siegel [États-Unis] ; Thierry Sornasse [États-Unis] | Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. |
| 001152 (2018) |
Regitse H Jgaard Christensen [Danemark] ; Anne-Sophie Wedell-Neergaard [Danemark] ; Louise Lang Lehrskov [Danemark] ; Grit Elster Leg Rd [Danemark] ; Emma Berndt Dorph [Danemark] ; Stine Nymand [Danemark] ; Maria Korf Ball [Danemark] ; Morten Zacho [Danemark] ; Robin Christensen [Danemark] ; Helga Ellingsgaard [Danemark] ; Jaya Birgitte Rosenmeier [Danemark] ; Rikke Krogh-Madsen [Danemark] ; Bente Klarlund Pedersen [Danemark] ; Kristian Karstoft [Danemark] | The role of exercise combined with tocilizumab in visceral and epicardial adipose tissue and gastric emptying rate in abdominally obese participants: protocol for a randomised controlled trial. |
| 001155 (2018) |
Masatoshi Matsunami [Japon] ; Yoshifumi Ubara [Japon] ; Keiichi Sumida [Japon] ; Yoichi Oshima [Japon] ; Masahiko Oguro [Japon] ; Kazuya Kinoshita [Japon] ; Kiho Tanaka [Japon] ; Yuki Nakamura [Japon] ; Keiichi Kinowaki [Japon] ; Kenichi Ohashi [Japon] ; Takeshi Fujii [Japon] ; Takuro Igawa [Japon] ; Yasuharu Sato [Japon] ; Yasuo Ishii [Japon] | The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome. |
| 001157 (2018) |
Cesar Diaz-Torne [Espagne] ; Maria Dels Angels Ortiz [Espagne] ; Patricia Moya [Espagne] ; Maria Victoria Hernandez [Espagne] ; Delia Reina [Espagne] ; Ivan Castellvi [Espagne] ; Juan Jose De Agustin [Espagne] ; Diana De La Fuente [Espagne] ; Hector Corominas [Espagne] ; Raimon Sanmarti [Espagne] ; Carlos Zamora [Espagne] ; Elisabet Cant [Espagne] ; Silvia Vidal [Espagne] | The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab. |
| 001159 (2018) |
Masashi Narazaki [Japon] ; Tadamitsu Kishimoto [Japon] | The Two-Faced Cytokine IL-6 in Host Defense and Diseases. |
| 001160 (2018) |
Alexander Pfeil [Allemagne] ; Peter Oelzner [Allemagne] ; Peter Hellmann [Allemagne] | The Treatment of Giant Cell Arteritis in Different Clinical Settings. |
| 001166 (2018) |
Ali Berkant Avci [Turquie] ; Eugen Feist [Allemagne] ; Gerd Rüdiger Burmester [Allemagne] | Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference? |
| 001199 (2018) |
Matthew B. Carroll [États-Unis] ; Charles Haller [États-Unis] ; Christopher Smith [États-Unis] | Short-term application of tocilizumab during myocardial infarction (STAT-MI). |
| 001209 (2018) |
Eric G. Boyce [États-Unis] ; Edward L. Rogan [États-Unis] ; Deepti Vyas [États-Unis] ; Neel Prasad [États-Unis] ; Yvonne Mai [États-Unis] | Sarilumab: Review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis. |
| 001218 (2018) |
I. Serio [Italie] ; F. Tovoli [Italie] | Rheumatoid arthritis: new monoclonal antibodies. |
| 001243 (2018) |
Golam M. Khandaker [Royaume-Uni] ; Bianca P. Oltean [Royaume-Uni] ; Muzaffer Kaser [Royaume-Uni] ; Claire R M. Dibben [Royaume-Uni] ; Rajini Ramana [Royaume-Uni] ; Deepak R. Jadon [Royaume-Uni] ; Robert Dantzer [États-Unis] ; Alasdair J. Coles [Royaume-Uni] ; Glyn Lewis [Royaume-Uni] ; Peter B. Jones [Royaume-Uni] | Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation. |
| 001282 (2018) |
Ernest H S. Choy [Royaume-Uni] ; Leonard H. Calabrese [États-Unis] | Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis. |
| 001291 (2018) |
Chuanfei Yu [République populaire de Chine] ; Junxia Cao [République populaire de Chine] ; Lan Wang [République populaire de Chine] ; Yalan Yang [République populaire de Chine] ; Yongbo Ni [République populaire de Chine] ; Junzhi Wang [République populaire de Chine] | Measuring the bioactivity of anti-IL-6/anti-IL-6R therapeutic antibodies: presentation of a robust reporter gene assay. |
| 001316 (2018) |
Hiroki Wakabayashi [Japon] ; Takahiko Hamaguchi [Japon] ; Nobuto Nagao [Japon] ; Sho Kato [Japon] ; Takahiro Iino [Japon] ; Tomoki Nakamura [Japon] ; Akihiro Sudo [Japon] | Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line. |
| 001317 (2018) |
Ola Kleveland [Norvège] ; Thor Ueland [Norvège] ; Gabor Kunszt [Norvège] ; Marte Bratlie [Norvège] ; Arne Yndestad [Norvège] ; Kaspar Broch [Norvège] ; Espen Holte [Norvège] ; Liv Ryan [Norvège] ; Brage H. Amundsen [Norvège] ; Bj Rn Bendz [Norvège] ; Svend Aakhus [Norvège] ; Terje Espevik [Norvège] ; Bente Halvorsen [Norvège] ; Tom E. Mollnes [Norvège] ; Rune Wiseth [Norvège] ; Lars Gullestad [Norvège] ; P L Aukrust [Norvège] ; Jan Kristian Dam S [Norvège] | Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction. |
| 001318 (2018) |
Neus Quilis [Espagne] ; Mariano Andrés [Espagne] ; Paloma Vela [Espagne] ; Eliseo Pascual [Espagne] | Interleukin-6 pathway blockade as an option for managing refractory cases of crystal arthritis: Two cases report. |
| 001333 (2018) |
M. Maldonado-Montoro [Espagne] ; M. Ca Adas-Garre [Espagne] ; A. González-Utrilla [Espagne] ; M. Ángel Calleja-Hernández [Espagne] | Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis. |
| 001334 (2018) |
Margarida Figueiredo-Braga [Portugal] ; Caleb Cornaby [États-Unis] ; Alice Cortez [Portugal] ; Miguel Bernardes [Portugal] ; Georgina Terroso [Portugal] ; Marta Figueiredo [Portugal] ; Cristina Dos Santos Mesquita [Portugal] ; Lúcia Costa [Portugal] ; Brian D. Poole [États-Unis] | Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis. |
| 001348 (2018) |
Nirmala Chandralega Kampan [Australie] ; Sue D. Xiang [Australie] ; Orla M. Mcnally [Australie] ; Andrew N. Stephens [Australie] ; Michael A. Quinn [Australie] ; Magdalena Plebanski [Australie] | Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities. |
| 001357 (2018) |
Rui Wu [République populaire de Chine] ; Xuanchen Liu [République populaire de Chine] ; Jianyong Yin [République populaire de Chine] ; Huijuan Wu [République populaire de Chine] ; Xiulei Cai [République populaire de Chine] ; Niansong Wang [République populaire de Chine] ; Youcun Qian [République populaire de Chine] ; Feng Wang [République populaire de Chine] | IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice. |
| 001359 (2018) |
Atsuhiko Iuchi [Japon] ; Hiroshi Harada [Japon] ; Toshio Tanaka [Japon] | IL-6 blockade for myocardial infarction. |
| 001360 (2018) |
Hilde L. Orrem [Norvège] ; Per H. Nilsson [Norvège] ; S Ren E. Pischke [Norvège] ; Ola Kleveland [Norvège] ; Arne Yndestad [Norvège] ; Karin Ekholt [Norvège] ; Jan K. Dam S [Norvège] ; Terje Espevik [Norvège] ; Bj Rn Bendz [Norvège] ; Bente Halvorsen [Norvège] ; Ida Gregersen [Norvège] ; Rune Wiseth [Norvège] ; Geir Andersen [Norvège] ; Thor Ueland [Norvège] ; Lars Gullestad [Norvège] ; P L Aukrust [Norvège] ; Andreas Barratt-Due [Norvège] ; Tom E. Mollnes [Norvège] | IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction. |
